Kintegral Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$3.07M	Sell	6,895 -10	-0.1%	-$4.45K	0.28%	93
2025 Q1	$3.35M	Sell	6,905 -23	-0.3%	-$11.2K	0.34%	89
2024 Q4	$2.79M	Sell	6,928 -323	-4%	-$130K	0.26%	99
2024 Q3	$3.37M	Sell	7,251 -95	-1%	-$44.2K	0.31%	94
2024 Q2	$3.44M	Sell	7,346 -2,748	-27%	-$1.29M	0.33%	90
2024 Q1	$4.22M	Sell	10,094 -31	-0.3%	-$13K	0.42%	68
2023 Q4	$4.12M	Sell	10,125 -64	-0.6%	-$26K	0.46%	56
2023 Q3	$3.54M	Sell	10,189 -6	-0.1%	-$2.09K	0.44%	66
2023 Q2	$3.59M	Hold	10,195	–	–	0.43%	71
2023 Q1	$3.21M	Sell	10,195 -548	-5%	-$173K	0.41%	77
2022 Q4	$3.1M	Sell	10,743 -3,912	-27%	-$1.13M	0.41%	83
2022 Q3	$4.24M	Hold	14,655	–	–	0.59%	40
2022 Q2	$4.13M	Buy	14,655 +310	+2%	+$87.4K	0.54%	45
2022 Q1	$3.74M	Buy	14,345 +320	+2%	+$83.5K	0.41%	56
2021 Q4	$3.08M	Hold	14,025	–	–	0.32%	75
2021 Q3	$2.54M	Hold	14,025	–	–	0.3%	79
2021 Q2	$2.83M	Hold	14,025	–	–	0.33%	72
2021 Q1	$3.01M	Hold	14,025	–	–	0.39%	68
2020 Q4	$3.32M	Hold	14,025	–	–	0.45%	57
2020 Q3	$3.82M	Sell	14,025 -451	-3%	-$123K	0.58%	41
2020 Q2	$4.2M	Hold	14,476	–	–	0.68%	34
2020 Q1	$3.45M	Buy	14,476 +1,619	+13%	+$385K	0.67%	39
2019 Q4	$2.82M	Hold	12,857	–	–	0.51%	54
2019 Q3	$2.18M	Hold	12,857	–	–	0.43%	68
2019 Q2	$2.36M	Hold	12,857	–	–	0.48%	56
2019 Q1	$2.37M	Sell	12,857 -156	-1%	-$28.7K	0.5%	55
2018 Q4	$2.16M	Buy	+13,013	New	+$2.16M	0.64%	40